During the past decade, Ivanovo Regional Oncology Dispensary conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 13 clinical trials were completed, i.e. on average, 48.1% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 10 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ivanovo Regional Oncology Dispensary" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Janssen Research & Development, LLC" with 6 trials sponsored, "Incyte Corporation" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "BeiGene" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ivanovo Regional Oncology Dispensary" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Ivanovo Regional Oncology Dispensary" are "Breast Cancer" (6 trials), "Early Breast Cancer" (2 trials), "Gastric Cancer" (2 trials), "Prostatic Neoplasms" (2 trials) and "Triple Negative Breast Cancer" (2 trials). Many other conditions were trialed in "Ivanovo Regional Oncology Dispensary" in a lesser frequency.

Most popular intervention types in "Ivanovo Regional Oncology Dispensary" are "Drug" (30 trials), "Other" (4 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Docetaxel" (5 trials), "Paclitaxel" (5 trials), "Atezolizumab" (4 trials) and "Cisplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ivanovo Regional Oncology Dispensary" are 22 trials for "All" genders, 8 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Ivanovo Regional Oncology Dispensary". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Ivanovo Regional Oncology Dispensary, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ivanovo Regional Oncology Dispensary, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".